glioblastoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The participants of this study voluntarily enrolled, signed an informed consent form, and had good compliance; 2. Age: 18-75 years old (when signing the informed consent form), regardless of gender; ECOG score: 0-2 points (KPS score = 60 points); 3. Glioblastoma was considered through head MRI examination; 4. Female participants of childbearing age should agree to use contraceptive measures (such as intrauterine devices, contraceptives, or condoms) during the study period and within 3 months after the end of the study; Within 7 days prior to enrollment, the serum pregnancy test was negative and must be a non lactating subject; Male participants should agree to use contraceptive measures during the study period and within 6 months after the end of the study period; 5. The participants are able to metabolize the tracer normally; 6. The participants compliance is good.
Exclusion criteria
Exclusion criteria: 1. The participants has previously received any treatment for gliomas; 2. The participants who cannot undergo MRI examination; 3. The participants cannot accept surgical treatment aimed at large-scale resection of the lesion; 4. Diffuse meningeal dissemination evident on imaging; 5. The subject cannot lie flat for half an hour; 6. The participants with claustrophobia or other mental illnesses; 7. According to the researcher's judgment, there are accompanying diseases that seriously endanger the safety of the subjects or affect the completion of the study, or subjects who are deemed unsuitable for enrollment due to other reasons;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accuracy of diagnosis; | — |
Countries
China
Contacts
Tangdu Hospital,Fourth Military Medical University